A
Aiforia Technologies
Biotech & Life Sciences · Helsinki, Finland · Founded 2013 · IPO 2021
AI-powered pathology image analysis software for researchers MoreLess
Aiforia Technologies is a Finnish medical software company that provides a cloud-based platform for AI-powered image analysis. Founded in 2013 as a spin-off from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki, the company was established by researchers Johan and Mikael Lundin, along with life science entrepreneur Kari Pitkänen. The company's technology has roots in research dating back to the early 2000s at the university. Aiforia went public, listing on the Nasdaq First North Growth Market in Helsinki in December 2021.
The company's core business is providing Software as a Service (SaaS) solutions and expert services to pathologists and scientists in clinical, preclinical, and academic laboratories. Aiforia's platform utilizes deep learning AI to increase the speed, accuracy, and consistency of analyzing complex medical images, particularly in pathology. Its primary product, Aiforia Create, allows users to develop their own AI models for image analysis without needing coding experience. The company serves a global client base, including pharmaceutical companies, research institutions, and healthcare providers like the Mayo Clinic. The business model is subscription-based, with fees determined by usage, cloud storage, and the number of users, which creates high customer stickiness.
Aiforia offers solutions for clinical diagnostics, preclinical research, and veterinary pathology. The platform assists in automating routine tasks and supports pathologists in diagnosing diseases like cancer by analyzing digital tissue and cell samples. For the research market, the software helps in discovering new biomarkers and accelerating drug development. The company's clinical suites, such as those for breast and lung cancer, are CE-IVD marked for diagnostic use in Europe. Aiforia has raised significant funding, including a Series B round in 2021, to expand its global presence and develop new diagnostic platforms.
Keywords: digital pathology, AI image analysis, medical software, cloud-based platform, deep learning, computational pathology, cancer diagnostics, preclinical research, clinical labs, SaaS, medical imaging, biomarker discovery, veterinary pathology, tissue analysis, cell analysis, CE-IVD, automated diagnostics, pathology workflow, oncology, neuroscience
Company overview
Aiforia Technologies company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- Helsinki, Finland
- Employees
- 78
- Open positions
- 4
- Dealroom signal
- 74.7
Valuation & funding
Aiforia Technologies funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Jul 2026 | $22M | — | European Investment Bank | ↗ |
| POST IPO EQUITY✓Other financing | Jun 2026 | $7M | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | Dec 2025 | $4.6M | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | May 2025 | $8.8M | — | Undisclosed | ↗ |
| IPO✓Exit | Dec 2021 | $0 | — | Undisclosed | — |
| SERIES B✓Equity / VC | Jun 2021 | Phc · Aktia Nordic Micro Cap · Epredia | — | ||
| SERIES A✓Equity / VC | Dec 2017 | Ascend Capital Partners · STO-Rahoitus · ACME Investments | ↗ | ||
| SEED✓Equity / VC | Jan 2016 | Kaikarhenni Oy | — | ||
| SEED✓Equity / VC | Oct 2015 | Business Finland | ↗ | ||
| EARLY VC✓Equity / VC | Jan 2015 | Mårten Mickos · Jukka Tapaninen | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $3.9M | 0% | 79 |
| 2025 | $3.9M | +23.9% | 86 |
| 2024 | $3.1M | +18.9% | 84 |
| 2023 | $2.6M | +49.3% | 88 |
| 2022 | $1.8M | -49.5% | 63 |
| 2021 | $3.5M | +34.6% | 50 |
| 2020 | $2.6M | — | 29 |
Growth signals
Aiforia Technologies website traffic
Latest recorded traffic for Aiforia Technologies is 27K monthly website visits, down 6.9% over the last three months. Aiforia Technologies's team declined 9.3% over the past year.
Hiring
Open positions at Aiforia Technologies
Current openings linked to this company in Dealroom.
Comparisons
Aiforia Technologies compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Aiforia Technologies's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on Aiforia Technologies's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Aiforia Technologies has talent and traffic
team presence
In the news
Latest news about Aiforia Technologies
Recent press, funding announcements, and product moves mentioning Aiforia Technologies — open to read from the original sources.
Market sentiment
What the market is saying about Aiforia Technologies
An AI-synthesized read of the highest-engagement posts about Aiforia Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aiforia Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.